C.R. Bard is facing hundreds of Avaulta mesh lawsuits over its Avaulta pelvic mesh products. Bernstein Liebhard LLP is already representing numerous women in transvaginal mesh lawsuits in state and federal courts, and is offering free legal evaluations to individuals injured by a C.R. Bard Avaulta mesh product, including:
- Avaulta Plus BioSynthetic Support System
- Avaulta Solo Synthetic Support System
- Faslata Allograft
- Pelvico Tissue
- PelviSoft Biomesh
- Pelvitex Polypropylene Mesh
If you or a woman you love received one of these C.R. Bard Avaulta mesh devices during surgery to treat pelvic organ prolapse or stress urinary incontinence, you may be entitled to file an Avaulta mesh lawsuit to obtain compensation for your medical bills , lost wages, pain and suffering, and other damages. The attorneys at Bernstein Liebhard LLP would be glad to answer any questions you have regarding Avaulta mesh injuries, and can advise you of the best way to proceed with your case. To learn more about filing an Avaulta mesh lawsuit, please give us a call today.
Avaulta Mesh Complications
Avaulta mesh devices are implanted to support weakened pelvic muscles in women with pelvic organ prolapse and stress urinary incontinence. Like other transvaginal mesh devices, Avaulta pelvic mesh products were approved through the U.S. Food & Drug Administration’s (FDA) 510(k) clearance system, which allows medical manufacturers to sidestep human testing. In October 2008, the FDA issued the first of two Safety Notifications warning the public that there had been reports of “rare” but “serious” complication associated with mesh placement in some women. In 2011, the FDA changed its stance, stating that transvaginal mesh complications in prolapse repair were not rare. By that time, more than 3,500 reports of complications had been linked to Avaulta mesh and other pelvic mesh devices. According to the FDA alert, the most common side effects reported in association with transvaginal mesh included:
- Erosion of the mesh through the vaginal wall
- Infection and bleeding
- Mesh shrinkage
- Bowel, bladder, and blood vessel perforation
- Pain and discomfort during sex
- Painful urination
- Recurrence of prolapse
In January 2012, the FDA issued an order to C.R. Bard and other transvaginal mesh manufacturers, requiring them to study their products’ risks. The FDA is now considering reclassifying transvaginal mesh as a high-risk medical device.
Avaulta Mesh Litigation
Since the FDA started issuing health alerts about transvaginal mesh complications, hundreds of women have filed lawsuits in both state and federal courts over alleged Avaulta mesh injuries. Two consolidated Avaulta mesh litigations have been established in U.S. District Court, Southern District of West Virginia, and in New Jersey’s Atlantic County Superior Court. Bernstein Liebhard LLP partner, Jeffrey S. Grand, is serving as Co-Liasion Counsel in the New Jersey Avaulta litigation, and was named a member of the Plaintiff’s Steering Committee in the federal litigation in West Virginia.
In July 2012, a California woman and her husband were awarded $5.5 million in damages in an Avaulta mesh lawsuit filed against C.R. Bard. According to her complaint, the plaintiff had received an Avaulta mesh product to treat incontinence. By the time she filed her lawsuit, the plaintiff had already undergone eight corrective surgeries to repair damage done by the Avaulta implant, and she faced the prospect of future surgeries to remove remaining mesh.
Have Questions about Avaulta Mesh Lawsuits? Contact an Attorney Today
If you were injured by Avaulta mesh and are considering legal action, it’s important to keep track of your medical appointments, days off work and other expenses related to your injury. You should also obtain a copy of your medical records from your doctor. To learn more about the process for filing an Avaulta mesh lawsuit, please contact Bernstein Liebhard LLP today, by calling 1-888-217-3033.